RPS6KB1 and breast cancer: We also compared the individual gene expression profiles between Ly294002- and rapamycin-treated and RPS6KB1-suppressed BT-474 and MCF-7 breast cancer cell lines to identify genes downstream of PI3K/mTOR/p70S6K pathway.